InsiderClue
← All stocks

Bausch Health Companies Inc.

BHC Net buying
CIK 0000885590 #1855 in the set updated 17 Sep 2026
Bought (120 mo)
$644.02M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$393.43M
$810.34K on a plan · $6.85M straight out of an exercise
Sold at will
$385.77M
23 of 43 sales
Net
+$250.59M
+$258.25M against sales at will

By person

42 insiders · 97 transactions
13.1×

Thomas J. Appio holds 13.1 times base salary in stock. $16.28M of shares against $1.24M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas J. Appio last reported holding, valued at $7.03, the price Common Shares, No Par Value was last bought or sold at on the open market here, on 19 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Paulson John
Director
$566.66M (22)
$113.78M (2)
+$452.88M
97,025,146
25.94%
$682.09M
+101.0%
Pershing Square Capital Management, L.P. entity
See footnote (3)
—
$250.89M (2)
−$250.89M
0
0.0000%
$0.00
−100.0%
ValueAct Holdings, L.P. entity
Director
$50.71M (3)
$18.25M (1)
+$32.47M
17,931,594
4.79%
$126.06M
+19.2%
PAULSON & CO. INC. entity
10% owner
$15.63M (1)
—
+$15.63M
73,255,869
19.59%
$514.99M
+3.5%
DE SCHUTTER RICHARD U
Director
$4.80M (12)
—
+$4.80M
387,207
0.1035%
$2.72M
+10,668%
ACKERMANN CHRISTINA
EVP AND GENERAL COUNSEL
$80.11K (1)
$4.53M (5) scheduled
−$4.45M
162,240
0.0434%
$1.14M
+172.3%
PAPA JOSEPH C
Director
$2.56M (4)
—
+$2.56M
1,427,568
0.3817%
$10.04M
+148.1%
Humphries William D.
President, Ortho-Dermatologics
$650.14K (1)
$3.08M (5) scheduled
−$2.43M
235,035
0.0628%
$1.65M
—
Miller Steven D
Director
$1.45M (2)
—
+$1.45M
239,224
0.0640%
$1.68M
+239,124%
Herendeen Paul
EVP and CFO
$724.85K (3)
—
+$724.85K
386,618
0.1034%
$2.72M
+157.7%
APPIO THOMAS
Chief Executive Officer
$584.02K (1)
—
+$584.02K
2,315,374
0.6191%
$16.28M
+10,765%
Eldessouky Sam
EVP & Chief Financial Officer
—
$538.59K (1)
−$538.59K
119,455
0.0319%
$839.77K
+122.1%
Gordon Joseph F
Pres&Co-Head Bausch&Lomb/Int'l
—
$494.47K (3)
−$494.47K
93,139
0.0249%
$654.77K
+130.6%
Carson Seana
EVP, General Counsel
—
$421.37K (14) scheduled
−$421.37K
616,761
0.1649%
$4.34M
+799.5%
WECHSLER AMY B
Director
—
$350.81K (1)
−$350.81K
314,979
0.0842%
$2.21M
+1,804%
Spurr Robert
President, U.S. Businesses
—
$348.16K (5)
−$348.16K
112,741
0.0301%
$792.57K
+180.1%
Lenar Aimee J.
President, US Pharma
—
$258.89K (1) scheduled
−$258.89K
334,853
0.0895%
$2.35M
—
Lee Frank D.
Director
—
$254.68K (2) scheduled
−$254.68K
95,210
0.0255%
$669.33K
—
McKenna Mark C.
President, Salix
—
$235.22K (1)
−$235.22K
20,756
0.0055%
$145.91K
−1.8%
Ross Thomas W. Sr.
Director
$112.49K (2)
—
+$112.49K
161,516
0.0432%
$1.14M
+654.1%
VON ESCHENBACH ANDREW C.
Director
$56.31K (2)
—
+$56.31K
38,647
0.0103%
$271.69K
+3,765%
Hale David Robert
Director
—
—
—
18,908,638
5.06%
$132.93M
+0.3%
Charhon Jean-Jacques
EVP, CFO
—
—
—
706,478
0.1889%
$4.97M
—
Kellen Ari
EVP, Company Group Chairman
—
—
—
630,842
0.1687%
$4.43M
−3.1%
Vadaketh Tom George
EVP, Chief Financial Officer
—
—
—
564,933
0.1511%
$3.97M
+455.9%
Rosiello Robert L.
EVP, Corp Dev & Strategy
—
—
—
517,683
0.1384%
$3.64M
−2.9%
POWER ROBERT N
Director
—
—
—
300,594
0.0804%
$2.11M
+827.2%
KAVANAGH SARAH B
Director
—
—
—
282,230
0.0755%
$1.98M
+1,908%
ROBERTSON RUSSEL C
Director
—
—
—
225,279
0.0602%
$1.58M
+1,322%
ICAHN BRETT
Director
—
—
—
220,280
0.0589%
$1.55M
—
Barresi John S
SVP, Controller & CAO
—
—
—
192,268
0.0514%
$1.35M
—
Whitaker Anne Clem
EVP, Company Group Chairman
—
—
—
158,885
0.0425%
$1.12M
−3.9%
Mulligan Richard
Director
—
—
—
155,616
0.0416%
$1.09M
+340.1%
Garcia Christian A
Director
—
—
—
135,578
0.0363%
$953.11K
—
KARABELAS ARGERIS N
Director
—
—
—
123,715
0.0331%
$869.72K
+508.8%
LEUNG SANDRA
Director
—
—
—
97,070
0.0260%
$682.40K
—
INGRAM ROBERT ALEXANDER
Director
—
—
—
92,046
0.0246%
$647.08K
+5.1%
GOETTLER MICHAEL
Director
—
—
—
76,020
0.0203%
$534.42K
—
LEE STEVEN HYOSIG
SVP, Controller & CAO
—
—
—
70,114
0.0187%
$492.90K
—
ROBERTS EIRY
Director
—
—
—
45,871
0.0123%
$322.47K
—
ESHELMAN FREDRIC N
Director
—
—
—
38,298
0.0102%
$269.23K
+115.2%
Munsch Frederick
SVP, Controller and CAO
—
—
—
22,435
0.0060%
$157.72K
+6.0%

Individual transactions

54
Insider
Date
Role
Action
Shares
Price
Amount
PAULSON & CO. INC.
25 Nov 2025
10% owner
Buy indirect
2,500,000
$6.25
$15.63M
Paulson John
14 Aug 2025
Director
Buy indirect
34,721,118
$9.00
$312.49M
Paulson John
13 Aug 2025
Director
Buy indirect
86,409
$7.06
$610.05K
Paulson John
12 Aug 2025
Director
Buy indirect
1,156,640
$6.88
$7.96M
Paulson John
11 Aug 2025
Director
Buy indirect
2,000,000
$6.35
$12.70M
Paulson John
13 Jun 2025
Director
Buy indirect
3,564,059
$5.94
$21.17M
Paulson John
12 Jun 2025
Director
Buy indirect
1,005,376
$5.47
$5.50M
Paulson John
11 Jun 2025
Director
Buy indirect
1,029,098
$5.24
$5.39M
Paulson John
10 Jun 2025
Director
Buy indirect
754,134
$5.05
$3.81M
Miller Steven D
30 Nov 2021
Director
Buy indirect
10,000
$24.17
$241.70K
Miller Steven D
30 Nov 2021
Director
Buy
50,000
$24.24
$1.21M
VON ESCHENBACH ANDREW C.
5 Aug 2021
Director
Buy
1,400
$25.94
$36.32K
DE SCHUTTER RICHARD U
4 Aug 2021
Director
Buy
10,000
$25.01
$250.12K
ValueAct Holdings, L.P.
5 Jun 2020
Director
Buy indirect
948,353
$19.24
$18.25M
Paulson John
14 May 2020
Director
Buy indirect
585,100
$15.92
$9.31M
Paulson John
14 May 2020
Director
Buy indirect
624,900
$15.87
$9.92M
Paulson John
14 May 2020
Director
Buy indirect
70,000
$15.65
$1.10M
Paulson John
14 May 2020
Director
Buy indirect
348,920
$15.85
$5.53M
Paulson John
13 May 2020
Director
Buy indirect
645,844
$16.70
$10.79M
Paulson John
13 May 2020
Director
Buy indirect
80,300
$16.58
$1.33M
Paulson John
13 May 2020
Director
Buy indirect
603,900
$16.32
$9.86M
Paulson John
12 May 2020
Director
Buy indirect
799,900
$17.24
$13.79M
Paulson John
12 May 2020
Director
Buy indirect
678,400
$17.47
$11.85M
Paulson John
12 May 2020
Director
Buy indirect
374,836
$17.33
$6.50M
Paulson John
12 May 2020
Director
Buy indirect
162,900
$17.50
$2.85M
Paulson John
12 May 2020
Director
Buy indirect
25,000
$17.30
$432.50K
Ross Thomas W. Sr.
12 Mar 2020
Director
Buy
2,500
$15.54
$38.84K
DE SCHUTTER RICHARD U
10 Mar 2020
Director
Buy indirect
3,800
$18.26
$69.38K
VON ESCHENBACH ANDREW C.
10 Mar 2020
Director
Buy
1,100
$18.18
$20.00K
ACKERMANN CHRISTINA
10 Mar 2020
EVP AND GENERAL COUNSEL
Buy
4,390
$18.25
$80.11K
DE SCHUTTER RICHARD U
3 Mar 2020
Director
Buy
5,000
$23.08
$115.42K
PAPA JOSEPH C
13 Sep 2019
CHAIRMAN & CEO
Buy
30,000
$23.31
$699.30K
Humphries William D.
16 Aug 2019
President, Ortho-Dermatologics
Buy
30,703
$21.18
$650.14K
PAPA JOSEPH C
28 Feb 2019
CHAIRMAN & CEO
Buy
30,000
$23.67
$710.10K
APPIO THOMAS
14 Dec 2018
Pres&Co-Head Bausch&Lomb/Int'l
Buy
25,440
$22.96
$584.02K
PAPA JOSEPH C
14 Sep 2018
CHAIRMAN & CEO
Buy
30,000
$22.32
$669.60K
Herendeen Paul
14 Sep 2018
EVP and CFO
Buy
10,000
$22.61
$226.10K
DE SCHUTTER RICHARD U
13 Sep 2018
Director
Buy
125,000
$23.96
$3.00M
DE SCHUTTER RICHARD U
15 May 2018
Director
Buy
15,000
$21.83
$327.45K
DE SCHUTTER RICHARD U
15 May 2018
Director
Buy indirect
10,000
$21.80
$218.00K
PAPA JOSEPH C
13 Mar 2018
CHAIRMAN & CEO
Buy
30,000
$16.05
$481.50K
Herendeen Paul
13 Mar 2018
EVP and CFO
Buy
15,000
$16.10
$241.47K
DE SCHUTTER RICHARD U
8 Mar 2018
Director
Buy
10,000
$15.34
$153.40K
Paulson John
6 Mar 2018
Director
Buy indirect
7,066,629
$15.40
$108.83M
DE SCHUTTER RICHARD U
17 Nov 2017
Director
Buy
10,000
$14.33
$143.30K
Paulson John
16 Nov 2017
Director
Buy indirect
344,216
$14.40
$4.96M
DE SCHUTTER RICHARD U
21 Aug 2017
Director
Buy
4,900
$14.35
$70.32K
DE SCHUTTER RICHARD U
21 Aug 2017
Director
Buy
5,100
$14.31
$72.98K
DE SCHUTTER RICHARD U
11 May 2017
Director
Buy
20,000
$13.90
$278.00K
DE SCHUTTER RICHARD U
15 Mar 2017
Director
Buy
10,000
$10.80
$108.00K
ValueAct Holdings, L.P.
14 Mar 2017
Director
Buy indirect
2,500,000
$10.81
$27.03M
ValueAct Holdings, L.P.
14 Mar 2017
Director
Buy indirect
500,000
$10.88
$5.44M
Herendeen Paul
14 Mar 2017
EVP and CFO
Buy
24,000
$10.72
$257.28K
Ross Thomas W. Sr.
14 Dec 2016
Director
Buy
5,000
$14.73
$73.65K
Show all 97 transactions →

What was left out

Form 4 filings counted 539
Amendments (4/A) skipped 22
Filings about a different issuer 2
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 5
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 18,332,275
Sales filed before the plan box existed 22
History held since 4 Oct 2016